Dopaminergic Neurotoxicity Induces Parkinsonian-Like Phenotypes in Daphnia magna
Related Experiment Video
Updated: Oct 30, 2026

Phenotypic Profiling of MPTP-Induced Parkinsonian-like Behavioral Phenotypes in Zebrafish Larvae Based on Behavioral Experiment
Published on: May 15, 2026
Alba Julià-López1, Emma Moragrega-Knol2, Sergi Pujol Badell3
1Instituto de Diagnostico Ambiental y Estudios del Agua (IDAEA-CSIC), Department of Environmental Chemistry, Jordi Girona 18, Barcelona, 08034, Spain.
Abstract:
Parkinson's disease (PD) is associated with dopaminergic neurodegeneration, in which mitochondrial dysfunction and oxidative stress play central roles. However, environmentally relevant invertebrate models for studying dopaminergic neurotoxicity remain limited. Here, we developed a Parkinsonism-like model in Daphnia magna using sublethal exposures to the prototypical dopaminergic neurotoxicant MPTP [1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine] and the environmentally relevant pesticide rotenone. Both compounds induced concentration-dependent increases in reactive oxygen species, marked depletion of dopamine and related metabolites in the head, and a strong downregulation of key dopaminergic genes, indicating profound disruption of dopaminergic homeostasis and redox balance and providing evidence consistent with construct validity. These molecular alterations were accompanied by functional alterations consistent with face validity, including reduced hopping distance, increased low-locomotion states, impaired photomotor responses and habituation, altered phototaxis and colour preference, particularly after MPTP exposure, and reduced heart rate. Together, these findings support the potential utility of D. magna as a sensitive, integrative, and ecologically relevant model for investigating dopaminergic neurotoxicity and Parkinsonism-related adverse outcome pathways triggered by environmental chemicals.
More Related Videos
Related Concept Videos
Parkinson's Disease: Overview
Parkinson Disease ll: Pathophysiology
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

